Skip to main content
$0.580 (0%)

High

$0.59

Low

$0.57

Trades

36

Turnover

$59,341

Volume

102,948
30 June 2023 at 3:56pm
If you were already registered, log in here.

Short Interest

ASIC data, 3 Jul 2024

% Shorted

0.00%
vs 0.00% prior report

Most Shorted Rank

620th
of 717 shorted ASX stocks

Peak Short

9.59%
Jun 2012

Days to Cover

0.0
at 50d avg vol
Subject
NXS Ann: Director Retirement

NXS Ann: Market Update

NXS Ann: Appointment of new Managing Director and CEO

NXS Ann: 2023 AGM - Voting Results

NXS Ann: AGM Chair & Managing Director Addresses

NXS Ann: Quarterly Activity Report 31 March 2023 - Addendum

NXS Ann: Corporate Governance Statement and Appendix 4G

NXS Ann: 2023 AGM Notice of Meeting

NXS Ann: 2022 Annual Report

NXS Ann: Investor Presentation - Q1 2023

NXS Ann: Quarterly Activity Report - 31 March 2023

NXS Ann: Appendix 4C - 31 March 2023

NXS Ann: Notification of date of 2023 AGM

NXS Ann: Ceasing to be a substantial holder

NXS Ann: FY22 Investor Presentation

NXS Ann: Next Science FY22 Results and FY23 Outlook

NXS Ann: Appendix 4E / FY22 Financial Statements

NXS Ann: Full Year Results Investor Briefing

NXS Ann: Cleansing notice

NXS Ann: Notification regarding unquoted securities - NXS

NXS Ann: General Meeting - Voting Results

NXS Ann: Proposed issue of securities - NXS

NXS Ann: Cancel - Proposed issue of securities - NXS

NXS Ann: Proposed issue of securities - NXS

NXS Ann: Investor Presentation - Q4 2022

NXS Ann: Appendix 4C - 31 December 2022

NXS Ann: Quarterly Activity Report - 31 December 2022

NXS Ann: Notice of General Meeting

NXS Ann: Next Science secures A$10M convertible notes due 2024

NXS Ann: Change in substantial holding

NXS Ann: Investor Presentation - Q3 2022

NXS Ann: Investor Webinar

NXS Ann: Quarterly Activity Report - 30 September 2022

NXS Ann: Appendix 4C - 30 September 2022

NXS Ann: Next Science US Medicare accreditation signals growth

NXS Ann: Trading Halt

NXS Ann: Pause in Trading

NXS Ann: Next Science's XPERIENCE product cleared for sale in Canada

NXS Ann: Half Year Results Investor Presentation

NXS Ann: Half Year Report & Appendix 4D

NXS Ann: Half Year Results Investor Briefing

NXS Ann: Investor Presentation - Q2 2022

NXS Ann: Quarterly Activity Report - 30 June 2022

NXS Ann: Appendix 4C - 30 June 2022

NXS Ann: Change in substantial holding

NXS Ann: Cleansing notice

NXS Ann: Application for quotation of securities - NXS

NXS Ann: 2022 AGM - Voting Results

NXS Ann: AGM Chair & Managing Director Addresses

NXS Ann: Next Science to strengthen senior leadership presence in US

If you were already registered, log in here.

Similar Companies

ANN
AVR
MGZ
NAN
OSX
PNV
SDI
SDI
S88
MAV
CX8
MTX $12m raise
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS